Signature Ajuokenya image

Meningococcal A+C vaccine

Meningococcal (A+C) Vaccine Brands

Brand Name Manufacturer Name Distributor Drug Strength Packaging Formulation Formulation Strength Price
Mencevax A/C GSK Ltd. 50 doses KES 1,528
Meningococcal A+C Sanofi Ltd 1s KES 1,558

10s KES 3,098

Meningococcal (A+C) Vaccine More info
Mode Of Action

excite immune system to produce antibodies corresponding to the vaccine antigen

Drug Indication Active vaccination against meningococcal infections
Dosage Adult and children over three months: 0.5ml. Revaccination every 3-4yrs.
Special Information A highly purified lyophilized vaccine of meningococcus polysaccharides (strain A / C).
Drug Category DRUGS ACTING ON INFECTIONS
Drug Sub-Category Vaccines
Precautions Avoid use in Hemophilia, thrombocytopenia and on patients on anticoagulants as with all medicines that are given IM and they can cause hematoma.

Care should be taken to ensure the medicaation does not enter into blood vessel.

Immunosuppressive therapies such as radiation, Corticosteroids , antimetabolites, alkylating agents, and cytotoxic drugs can reduce the immune response to vaccines.

Contraindications Allergy to drugs components.
Pregnancy category C
2. Meningococcal Polysacharide Vaccine (Groups A, C, Y and W-135 Combined)
Mode Of Action

excite immune system to produce antibodies corresponding to the vaccine antigen

Drug Indication Active vaccination against meningococcal infections
Dosage Adult and children over three months: 0.5mL. Revaccination every 2-5yrs (depending on the risk factors).
Drug Category DRUGS ACTING ON INFECTIONS
Drug Sub-Category Vaccines
Brand Name Manufacturer Name Distributor Drug Strength Packaging Formulation Formulation Strength Price
Mencevax ACWY GSK Ltd. 50 doses KES 1,528
Menomune Sanofi Ltd 5 doses 1s KES 1,797

10s KES 17,977